In March 2014, the Society of Gynecological Oncologists issued a clinical practice statement recommending that women with epithelial ovarian, tubal and peritoneal cancers be referred for genetic counseling and testing, even in the absence of a family history. Despite this, there is under-identification of high risk patients. The Cancer Risk Management Program has been piloting an online family history questionnaire to assess a patient’s hereditary risk classification as compared to results obtained by a genetic counselor. Results from this study were presented this fall by Kristin Baker Niendorf, MS, CGC, at the Women’s Health Conference and Masonic Cancer Center Research Symposium, held at the University of Minnesota. View results from this study.
The Cancer Risk Management Program is now seeing both new and established patients at three new sites, including: Maple Grove Cancer Center, Lakes Cancer Clinic in Wyoming, MN, and The Journey Clinic: Center for Children with Cancer and Blood Diseases in Minneapolis. To make it easy for patients or referring providers to set up appointments at any of our eight locations, there is one central telephone number for intake and appointments: 855-486-7226. Referring providers in the UMN Health or Fairview systems may also make referrals through EPIC by ordering “Cancer Risk Mgmt/Cancer Genetic Counseling.”
Screening tools for hereditary breast cancer risk utilized at the time of a routine mammogram can identify patients who may have genetic mutations that cause an increased risk of breast cancer. We designed a Breast Cancer Risk Assessment Tool to identify patients at increased breast cancer risk (lifetime risk >20%) who may benefit from breast MRI screening and genetic counseling. Using the tool, we assessed all patients receiving mammograms at University of Minnesota Medical Center since Feb. 2012. Individuals that screened positive on the tool were referred to a breast specialist and/or cancer genetic counselor for further monitoring. Results from this pilot study were presented this fall by Melissa Truelson, MS, CGC.
Lynch syndrome, a dominantly inherited cancer syndrome, confers a predisposition to colorectal, endometrial, and other cancers. A patient's offspring and/or siblings have a 50% chance of inheriting it.Continue reading
Our Cancer Risk Management Program helps patients evaluate their risk of developing cancer and to work with them and their referring healthcare providers to manage cancer risk over the long term.Continue reading